Alliance Pharma PLC Exercise of Share Options (0943K)
June 19 2014 - 12:35PM
UK Regulatory
TIDMAPH
RNS Number : 0943K
Alliance Pharma PLC
19 June 2014
For immediate release 19 June 2014
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Exercise of Share Options
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that following the exercise of employee share
options on 19 June 2014, application has been made by Alliance for
a further 10,492 ordinary shares of 1 pence each in the Company
("Ordinary Shares") to be admitted to trading on AIM.
It is expected that these new Ordinary Shares, which will rank
pari passu in all respects with the existing Ordinary Shares, will
be admitted to trading on 25 June 2014.
Following the exercise of the options, Alliance will have
264,148,365 Ordinary Shares in issue.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
Buchanan + 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Oliver
Cardigan/Freddie Barnfield
Corporate Broking: David Poutney
Notes to editors:
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFVRRIIALIS
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024